GRMN
50
2
MCK
63
-3
ITW
52
2
LYB
41
7
AVB
50
-2
IP
53
5
IFF
59
-3
HBI
31
-6
PHM
37
2
LH
42
6
PX
52
2
NWL
8
2
PWR
41
-2
SJM
23
-5
EQIX
52
4
MNST
59
2
KMX
70
5
SWKS
36
8
JBHT
50
5
MSI
35
-11
GRMN
50
2
MCK
63
-3
ITW
52
2
LYB
41
7
AVB
50
-2
IP
53
5
IFF
59
-3
HBI
31
-6
PHM
37
2
LH
42
6
PX
52
2
NWL
8
2
PWR
41
-2
SJM
23
-5
EQIX
52
4
MNST
59
2
KMX
70
5
SWKS
36
8
JBHT
50
5
MSI
35
-11
Financhill
Back

ProShares Ultra VIX Short-Term Futures ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

UVXY
ProShares Ultra VIX Short-Term Futures ETF

Last Price:
$17.76
Seasonality Move:
7.18%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Sell
45
ProShares Ultra VIX Short-Term Futures ETF (UVXY) is a Sell

Is ProShares Ultra VIX Short-Term Futures ETF a Buy, Sell or Hold?

  • The current ProShares Ultra VIX Short-Term Futures ETF [UVXY] share price is $17.87. The Score for UVXY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • UVXY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UVXY Stock Price Chart

What is ProShares Ultra VIX Short-Term Futures ETF's stock price today?

  • The ProShares Ultra VIX Short-Term Futures ETF share price today is $17.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UVXY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

UVXY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 42.75 Sell
Chaikin Money Flow: -8594637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.78 - 20.48) Sell
Bollinger Bands (100): (18.57 - 26.09) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

UVXY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.41 Sell
20-day SMA: 18.64 Sell
50-day SMA: 19.53 Sell
200-day SMA: 24.35 Sell
8-day EMA: 18.39 Sell
20-day EMA: 18.83 Sell
50-day EMA: 19.92 Sell
200-day EMA: 31.16 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

ProShares Ultra VIX Short-Term Futures ETF Earnings Growth & UVXY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

ProShares Ultra VIX Short-Term Futures ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):